It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.

Diagnosing IRD

Retinal dystrophies can be categorized in several ways including if they are syndromic (those affecting other organ systems, e.g., Usher syndrome), or non-syndromic (those where the symptoms are solely vision-related) and by the subtype of cell that is predominantly affected.1-4

In conditions where rod cells are more severely affected, nighttime or low-light and peripheral vision will be affected before degeneration of the central macula and colour vision. In those where cone cells are primarily affected, the primary signs may be photophobia, poor central vision, and impaired colour vision before further visual impairment becomes apparent.3

Diagnosing IRD flow chart

Adapted from Fighting Blindness Canada Website and Atlas of Inherited Retinal Diseases.2,5

This video features a patient and her family discovering the symptoms and diagnosis of IRD. The family shares reasons for pursuing a genetic test and details their life after the diagnosis.

Signs and symptoms

Because of the number of diseases that are included in the term inherited retinal dystrophy, there are a wide range of different signs and symptoms that include loss of night vision, visual field, colour vision, and central acuity.3,6 Initial symptoms that may indicate a likelihood of an IRD include:

image of a smiling man, holding and looking down at a laughing baby

In babies and young children

  • Nystagmus (uncontrolled eye movements)3
  • Failure to fix and follow3
  • Photophobia (sensitivity to light)3
  • Undetectable ERG recording3
  • Reduced visual field and/or reduced light sensitivity3
  • Problems with hearing and balance (associated with Usher syndrome)3

 

Image of a woman wearing headphones and speaking, gesticulating with her hands and holding a pencil.

In older children, teenagers and adults

  • Loss of visual acuity1
  • Nyctalopia (loss of night vision)1,3
  • Problems seeing in dim or low light1
  • Slow eye response when switching from bright to dim light7

 

This video gives an idea of what it can be like to live with an IRD, to care for someone who has it, and also highlights some of the symptoms.

Clinical testing

Beyond standard visual field testing and retinal imaging, there are a number of testing options available to help confirm a diagnosis of a specific IRD.2,8 Some of the more commonly used examples are outlined below.

Electroretinogram

Using a skin electrode in young children or contact lens electrodes with older children and adults. Flash, pattern, and flicker light stimuli are used to detect photoreceptor response and function.2,8,9

 

line-break

Fundus autofluorescence

Lipofuscin, a fluorophore, is stored in the retinal pigment epithelium and can act as a surrogate marker of photoreceptor activity that can be picked up by fundus autofluorescence. Different patterns of fluorescence can indicate particular diagnoses.2

line-break

Optical coherence tomography (OCT)

OCT uses light reflection to visualize the structure of different layers of the retina in fine detail. It can be used to measure retinal thickening and to determine the level of progression of retinal dystrophies.2,10

 

line-break

Genetic testing

Previously, diagnosis of IRD has relied heavily on clinical testing. More recently there has been the development of new screening methods, and increasing interest in specific gene mutations.3,8

What is genetic testing?
Genetic testing is a medical test that studies human DNA to discover genetic changes or mutations that could lead to genetic disease. Genetic testing is performed on samples of DNA, usually from blood or saliva, and involves DNA sequencing to identify mutations. Most genetic testing looks at a panel of a few hundred genes that are known to be mutated in IRDs.2,11

Deciding if genetic testing would be appropriate for your patient
Genetic testing is appropriate for most patients with presumed genetically-caused retinal degeneration.8 
Consider testing if:

Patient exhibits signs and symptoms of an IRD

Symptoms of an IRD diagram

Other systems/organs:

  • Some IRDs can be syndromic and may affect other system/organs
    • E.g., Usher Syndrome also results in hearing loss3
       

Has a diagnosis of an inherited retinal dystrophy, or a family history of IRD8,11

Once your patient is suspected of having an IRD, consider ordering a genetic test as soon as possible. The wait times for genetic tests may be up to 1 to 2 years. 

Genetic testing provides more information about your patient's IRD and is the only way of confirming which genes are affected, and can help with diagnosis.2,8,11 Patients may benefit from access to a genetic counsellor when receiving a genetic diagnosis. The process for ordering a genetic test can differ across provinces and may be complex, but is generally as follows: 3,5 

1. An ophthalmologist or another physician specializing in medical genetics arranges for testing following a preliminary diagnosis. Click on the link below for a list of centers where genetic testing may be requested based on your location along with the associated referral forms:

Genetic testing centers by province:

https://www.cagc-accg.ca/index.php?page=225&id=

2. A genetic counsellor works with patients helping them to understand the purpose, benefits, risks, limitations, and the results of their genetic test.

3. DNA samples are taken with either blood or saliva; testing and counseling may take several months to years, depending on the province. 

4. If initial gene panel test results are inconclusive, whole exome sequencing can be used to improve the likelihood of a genetic diagnosis, as there are a number of genes associated with IRDs. 

ERG=electroretinography

References
1. Fahim AT, Daiger SP, Weleber RG. Nonsyndromic retinitis pigmentosa overview. In: Adam MP, Ardinger HH, Pagon RA, et al, eds. GeneReviews®. Seattle, WA: University of Washington, Seattle; 1993-2021.
2. Tsang SH, Sharma T, eds. Atlas of inherited retinal diseases. Adv Exp Med Biol. Cham, Switzerland: Springer; 2018.
3. EyeNet. https://www.aao.org/Assets/bebfbaef-a092-45b0-9883-c563331546ae/636649294795430000/july-2018-eyenet-supplement-pdf?inline=1. Accessed June 16, 2020.
4. Duncan JL, Pierce EA, Laster AM, et al. Trans Vis Sci Technol. 2018;7(4):6.
5. Fighting Blindness Canada. https://www.fightingblindness.ca/wp-content/uploads/2020/10/FBC_OnePager_GeneticTesting_English_VF_Web_Ontario.pdf. Accessed March 3, 2021.
6. Chung DC, Bertelsen M, Lorenz B, et al. Am J Ophthalmol. 2019;199:58-70.
7. Fighting Blindness Canada. https://www.fightingblindness.ca/eye-diseases-pathways/leber-congenital-amaurosis/. Accessed March 3, 2021.
8. American Academy of Ophthalmology. https://www.aao.org/clinical-statement/recommendations-on-clinical-assessment-of-patients. Published 2016. Accessed July 2, 2020.
9. McCulloch DL, Marmor MF, Brigell MG, et al. Doc Opthalmol. 2015;130(1):1-12.
10. Fighting Blindness Canada. https://www.fightingblindness.ca/glossary/optical-coherence-tomography/. Published March 22, 2020. Accessed March 3, 2021.
11. Fighting Blindness Canada. https://www.fightingblindness.ca/resources/genetic-testing-for-inherited-retinal-diseases/. Reviewed October 2020. Accessed January 18, 2021.
12. Patel U, Boucher M, de Léséleuc L, Visintini S. In: CADTH issues in emerging health technologies. Canadian Agency for Drugs and Technologies in Health issue: 2018:169.
13. Dolz-Marco R, Boon C, Gallego-Pinazo, Chhablani J. Dystrophies. In: Chhablani J, Ruiz-Medrano J, eds. Choroidal Disorders. Academic Press; 2017: 63-72.
bubble image